Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
3,433
-16
-0.5% -$5.48K 0.16% 81
2026
Q1
$1.21M Sell
3,449
-27
-0.8% -$9.63K 0.18% 81
2025
Q4
$1.14M Sell
3,476
-189
-5% -$60K 0.16% 84
2025
Q3
$1.03M Sell
3,665
-139
-4% -$40.3K 0.15% 89
2025
Q2
$1.06M Sell
3,804
-93
-2% -$26.3K 0.17% 87
2025
Q1
$1.21M Sell
3,897
-157
-4% -$46.4K 0.21% 80
2024
Q4
$1.06M Buy
+4,054
New +$1.2M 0.18% 85

Other funds holding AMGN

Crews Bank & Trust's AMGN Position: Q2 2026 in Review

Crews Bank & Trust reduced its Amgen (AMGN) stake by 0.46% in Q2 2026, selling an estimated $5.48K and leaving 3,433 shares worth $1.24M. The position accounts for 0.16% of the portfolio, ranked #81.

Crews Bank & Trust first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Crews Bank & Trust held 3,433 shares of Amgen worth $1.24M as of Q2 2026.
  • Crews Bank & Trust sold 16 Amgen shares in Q2 2026, an estimated $5.48K.
  • Amgen made up 0.16% of Crews Bank & Trust's portfolio in Q2 2026, its #81 holding.
  • Crews Bank & Trust first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.